Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile
Authors:
- Ellie J.C. GoldsteinEGEllie J.C. Goldstein
- Diane M. CitronDCDiane M. Citron
- Kerin L. TyrrellKTKerin L. Tyrrell
- Yumi A. WarrenYWYumi A. Warren
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Metronidazole Resistance in Clostridium difficile Is HeterogeneousJournal of Clinical Microbiology, 2008
- Emergence of reduced susceptibility to metronidazole in Clostridium difficileJournal of Antimicrobial Chemotherapy, 2008
- Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United StatesAntimicrobial Agents and Chemotherapy, 2008
- Comparison of Clinical and Microbiological Response to Treatment ofClostridium difficile–Associated Disease with Metronidazole and VancomycinClinical Infectious Diseases, 2008
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- Telavancin, a Multifunctional Lipoglycopeptide, Disrupts both Cell Wall Synthesis and Cell Membrane Integrity in Methicillin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2005
- In Vitro Activities of the New Semisynthetic Glycopeptide Telavancin (TD-6424), Vancomycin, Daptomycin, Linezolid, and Four Comparator Agents against Anaerobic Gram-Positive Species and Corynebacterium sppAntimicrobial Agents and Chemotherapy, 2004
- Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteriaJournal of Antimicrobial Chemotherapy, 2004